EDSA earnings date and last-quarter result: next report 2026-08-14, last quarter miss, P/E -4.24. Updated 2026-07-23.
Edesa Biotech (EDSA) Research Hub
Edesa Biotech (EDSA) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.59 USD (-6.50%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.24, market cap 0.05B. This hub links to the full technical, earnings and options research available for EDSA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 2.59 USD (-6.50%) |
| 52-week range | 2.52 USD – 8.89 USD |
| Trend regime | Range |
| 14-day RSI | 23.2 (Oversold) |
| Trailing P/E | -4.24 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-14 |
Available research for EDSA
Covered Call on EDSA: how it works, illustrative setup around the real 2.59 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EDSA: how it works, illustrative setup around the real 2.59 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EDSA: how it works, illustrative setup around the real 2.59 USD price, max profit/loss, breakeven and when to use it. Educational.
EDSA technical analysis: range, last 2.59 USD, RSI 23.2, 52w range 2.52 USD–8.89 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is EDSA in?
Edesa Biotech (EDSA) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.
Is EDSA in an uptrend or downtrend?
As of 2026-10-26, EDSA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EDSA's trailing P/E ratio?
EDSA's trailing P/E is -4.24, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does EDSA next report earnings?
EDSA is next scheduled to report earnings on 2026-08-14.